Brandon Beylo: Biotech investor achieves 35-fold account growth

Traders Union
All News
Market Voices
Biotech investor achieves 35x account growth

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

53 min ago

Brandon Beylo: Biotech investor achieves 35-fold account growth — Biotech investor achieves 35x account growth

Brandon Beylo shares news of a recent podcast interview with a biotech investor known as Seedy, who achieved 35-fold growth in his account by investing in biotech stocks.

The discussion focused on investment process, idea generation, and specific strategies within the biotech sector.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Beylo recently noted that Vertex Pharma announced the acquisition of Crinetics Pharma at a 100 percent premium. In another update, he suggested gold prices could still fall to $3,800 per ounce before recovering. These insights add context to his ongoing coverage of investment strategies and sector-specific developments.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

By Mikhail Vnuchkov
7 hours ago

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Editors' Picks

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

By Oleg Tkachenko
Yesterday

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

Editors' Picks

By Eugene Komchuk
08.07.2026

The crypto IPO problem: How high-profile listings became investor traps

Editors' Picks

All Editors' Top Picks

Latest Brandon Beylo News

Company pivots from biotech to copper exploration in Morocco, Brandon Beylo notes

By Andreas Kristo
08.07.2026

Company pivots from biotech to copper exploration in Morocco, Brandon Beylo notes

Market Voices

Brandon Beylo: Vertex Pharma acquires Crinetics Pharma at 100 percent premium

By Andrey Mastykin
06.07.2026

Brandon Beylo: Vertex Pharma acquires Crinetics Pharma at 100 percent premium

Market Voices

Crypto beating precious metals in next year would be hilarious, Brandon Beylo notes

By Yaroslav Dmytrenko
03.07.2026

Crypto beating precious metals in next year would be hilarious, Brandon Beylo notes

Market Voices

All Brandon Beylo News

Mikhail Vnuchkov
7 hours ago

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Oleg Tkachenko
Yesterday

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

Eugene Komchuk
08.07.2026

The crypto IPO problem: How high-profile listings became investor traps

Anastasiia Chabaniuk
07.07.2026

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Mikhail Vnuchkov
06.07.2026

Aiming for leadership: Payment giants prepare a new stablecoin

Yaroslav Dmytrenko
3 min ago

Circle surges over 15 percent after bank charter nod, Mario Nawfal reports

Andreas Kristo
8 min ago

James E. Thorne: Economic road map found in Bessent America 250 address

Dmytro Kharkov
12 min ago

Eighty percent of historical periods surpassed today’s economy, Eric Basmajian notes

Andrey Mastykin
13 min ago

Ted Cruz: Trump Accounts launch aims to boost wealth for young Americans

Parshwa Turakhiya
18 min ago

Fed policymakers commit to delivering price stability, Christophe Barraud notes

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Eugene Komchuk
1 hour ago

Circle wins approval to establish U.S. national trust bank

Circle wins approval to establish U.S. national trust bank

Ivan Andriyenko
2 hours ago

Oil market keeps risk premium as Hormuz traffic stalls

Oil market keeps risk premium as Hormuz traffic stalls

Igor Krasulya
4 hours ago

UAE oil output hits record high as Abu Dhabi pushes beyond OPEC limits

UAE oil output hits record high as Abu Dhabi pushes beyond OPEC limits

Eugene Komchuk
5 hours ago

Crypto market posts third consecutive quarterly loss

Crypto market posts third consecutive quarterly loss

Andrey Mastykin
5 hours ago

Nasdaq futures slip before SK Hynix U.S. debut

Nasdaq futures slip before SK Hynix U.S. debut

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Microsoft stabilizes as AI strategy remains in focus

Anton Kharitonov
Now

Apple extends rally as AI strategy strengthens investor confidence

Anton Kharitonov
Now

Google rebounds as AI momentum supports investor confidence

Mykhailo Ihnatenko
Now

Intel stock faces rising volatility ahead of earnings season

Anton Kharitonov
Now

Bitcoin climbs toward resistance as ETF demand improves

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.